Fernandez, Jocelyn D.
HRN: 19-19-87 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/24/2022
07/01/2022
IV
1.5gram
Q6hrs
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes